EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein

Shimeng Bai, Yanxin Cui, Qibin Liao, Hongyang Yi, Zhonghui Liao, Gengwei Zhang, Fenfang Wu, Hongzhou Lu

Viruses · 2025

DOI: 10.3390/v17010116 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Viruses, 2025. Verfasst von Shimeng Bai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bio-Therapeutic Center, Shenzhen Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's…. Hauptthemen laut MEDLINE: Immunoglobulin Fc Fragments, Antibody Specificity, Monkeypox virus, Recombinant Fusion Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen High-level Hospital Construction Fund, Shenzhen Medical Research Fund, Special Funds for Strategic Emerging Industry of Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The re-emergence of the mpox pandemic poses considerable challenges to human health and societal development. There is an urgent need for effective prevention and treatment strategies against the mpox virus (MPXV). In this study, we focused on the A35R protein and created a chimeric A35R-Fc protein by fusing the Fc region of IgG to its C-terminal. We then assessed its reactivity with A35R-specific antibodies and human convalescent plasma, as well as its immunogenicity. Our findings indicate that the A35R-Fc protein significantly enhances affinity to A35R antibodies compared to the commercially available A35R protein and exhibits considerable reactivity to human plasma. Additionally, mice immunized with A35R-Fc exhibited increased neutralizing antibody titers against the live MPXV. These results support the potential of Fc domain chimeric antigens as a strategy to enhance the efficacy of subunit vaccines targeting the MPXV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin Fc FragmentsAntibody SpecificityMonkeypox virusRecombinant Fusion ProteinsViral ProteinsFemaleAnimalsMiceAntibodies, NeutralizingCricetinaeCHO CellsCricetulusMpox, MonkeypoxHumans

Stichwörter der Autor:innen

A35R proteinFc fusion proteinMPXVmpoxmpox virus

Substanzen

Immunoglobulin Fc FragmentsRecombinant Fusion ProteinsViral ProteinsAntibodies, Neutralizing

Autor:innen und Institutionen

  • Bio-Therapeutic Center, Shenzhen Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Scienc…
  • School of Public Health, Bengbu Medical University, Bengbu 233030, China.

Förderung

  • Shenzhen High-level Hospital Construction Fund
  • Shenzhen Medical Research Fund
  • Special Funds for Strategic Emerging Industry of Shenzhen
  • the National Key Research and Development Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Bai, S., Cui, Y., Liao, Q., Yi, H., Liao, Z., Zhang, G., Wu, F., & Lu, H. (2025). Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein. Viruses. https://doi.org/10.3390/v17010116

Vancouver

Bai S, Cui Y, Liao Q, Yi H, Liao Z, Zhang G, et al. Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein. Viruses. 2025. doi:10.3390/v17010116

BibTeX
@article{Bai2025,
  author = {Bai, Shimeng and Cui, Yanxin and Liao, Qibin and Yi, Hongyang and Liao, Zhonghui and Zhang, Gengwei and Wu, Fenfang and Lu, Hongzhou},
  title = {Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17010116}
}
Kostenlos starten →